Kura Sushi USA Announces Election of Claudia Schaefer to the Company’s Board of Directors

(NasdaqGM:KRUS), IRVINE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that Claudia Schaefer has been elected to serve as an independent member of the Board of Directors effective January 21, 2026. In conjunction with Ms. Schaefer's nomination, Kim […]

Intuitive Announces Fourth Quarter Earnings

(NASDAQ:ISRG), SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

(NASDAQ:CRNX), SAN DIEGO, Jan. 22, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating investigational candidate atumelnant, a novel, once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist candidate for the proposed treatment of classic congenital adrenal hyperplasia (CAH) in children

Magnite to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

(NASDAQ:MGNI), NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the fourth quarter ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The Company will host a conference call at 1:30 PM (PT) / 4:30 PM (ET)

Nukkleus Inc. Provides Updates on Acquisitions and Outlines Its 2026 Growth Strategy

(NasdaqGM:NUKK),(NasdaqGM:SCIIU),(TASE:BLRN.TA), NEW YORK and TEL AVIV, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense industry, today issued a letter to its shareholders from Menny Shalom, the Company's Chief Executive Officer. Dear shareholders: 2025 has been

MondelĂ„”z International’s Global R&D Team Opens Applications for CoLab Tech 2026

(NASDAQ:MDLZ), Accelerator program helps advance emerging snack-centric technologies Focus areas include climate resilience, breakthrough performance technologies, next-generation ingredients and more sustainable packaging Curriculum designed to help companies achieve commercial viability and scalability through virtual sessions, 1:1 mentorship and potential proof of concept testing Applications are now open at snackfutures.com/colab-tech; up to 10 start-ups will be

Perimeter Solutions Completes Acquisition of MMT

(NYSE:PRM), CLAYTON, Mo., Jan. 22, 2026 (GLOBE NEWSWIRE) — Perimeter Solutions, Inc. (NYSE: PRM) (“Perimeter,” “Perimeter Solutions,” or the “Company”), today announced that it has completed the acquisition of Medical Manufacturing Technologies LLC (“MMT”) from Arcline Investment Management (“Arcline”) for approximately $685 million in cash, including certain tax benefits. The signing of the definitive agreement

CTO Realty Growth Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Information

(NYSE:CTO),(NYSE:PINE), WINTER PARK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the fourth quarter and full year of 2025 after the market closes on Thursday, February 19, 2026. A conference call to discuss its financial and operating

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:MDGL), CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on January 15, 2026 to 40 new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The

Scroll to Top